Instructions for Reviewers
The Journal of Biomedical Frontiers and Molecular Medicine (JBFMM) relies on the expertise and commitment of peer reviewers to uphold the quality, integrity, and scientific excellence of published research. We sincerely appreciate the valuable contributions made by reviewers to the scholarly communication process.
ACCEPTING A REVIEW INVITATION
Before accepting a review assignment, reviewers should ensure that:
- The manuscript falls within their area of expertise.
- They can provide an objective and unbiased evaluation.
- No conflicts of interest exist that may affect their judgment.
- They can complete the review within the requested timeframe.
If a reviewer is unable to accept an invitation, they are encouraged to decline promptly so that alternative reviewers may be invited.
REVIEWER RESPONSIBILITIES
Reviewers are expected to:
- Provide objective, constructive, and evidence-based evaluations of submitted manuscripts.
- Assess the originality, scientific quality, methodological rigor, and relevance of the research.
- Identify strengths, weaknesses, and areas requiring improvement.
- Maintain confidentiality throughout the review process.
- Declare any actual or potential conflicts of interest before accepting a review assignment.
- Submit review reports within 14-21 days of accepting the review invitation.
- Notify the Editorial Office promptly if additional time is required.
CONFIDENTIALITY
JBFMM operates a Double-Blind Peer Review process. Reviewers must treat all manuscripts and associated materials as confidential documents.
Reviewers should not:
- Share manuscript content with unauthorized individuals.
- Discuss unpublished findings outside the review process.
- Use information obtained through peer review for personal or professional advantage.
Any request to consult a colleague should be communicated to the Editorial Office in advance.
CONFLICT OF INTEREST
Reviewers should decline assignments if any conflict of interest could influence their assessment. Potential conflicts may include:
- Recent collaboration with the authors.
- Employment at the same institution as the authors.
- Financial, professional, or personal relationships related to the work.
- Direct academic or commercial competition.
Any potential conflict should be disclosed to the Editorial Office immediately.
EVALUATION CRITERIA
Reviewers are encouraged to assess manuscripts based on the following criteria:
Relevance and Scope
- Is the manuscript relevant to the aims and scope of JBFMM?
- Does it contribute meaningfully to biomedical sciences, molecular medicine, translational research, clinical investigation, biotechnology, genetics, genomics, pharmacology, immunology, or related disciplines?
Originality and Significance
- Does the study present novel findings, innovative methodologies, or meaningful scientific advances?
- Is the research question scientifically important and relevant to the field?
Scientific Quality
- Is the study design appropriate and rigorous?
- Are the methods adequately described and reproducible?
- Are statistical analyses appropriate and correctly interpreted?
Results and Conclusions
- Are the results clearly presented and supported by the data?
- Do the findings support the conclusions?
- Have study limitations been adequately discussed?
Ethical Compliance
- Has appropriate ethical approval been obtained where required?
- Are informed consent procedures reported for studies involving human participants?
- Are animal studies conducted according to accepted ethical standards?
Presentation and Clarity
- Is the manuscript well organized and clearly written?
- Are figures and tables relevant and of sufficient quality?
- Are references accurate, current, and appropriate?
Reviewer Recommendations
Following evaluation, reviewers may recommend one of the following decisions:
- Accept
- Minor Revision
- Major Revision
- Reject
Reviewers should provide clear and constructive comments to support their recommendation. Comments intended for authors should remain professional, respectful, and focused on improving the manuscript.
USE OF ARTIFICIAL INTELLIGENCE (AI)
To protect confidentiality and intellectual property, reviewers must not upload manuscript content, figures, data, or supplementary materials to publicly accessible generative AI platforms or services.
Reviewers remain fully responsible for the content, accuracy, and integrity of their review reports.
PUBLICATION ETHICS
JBFMM follows the principles and recommendations of the Committee on Publication Ethics (COPE).
Reviewers are encouraged to alert the Editorial Office to any concerns regarding:
- Plagiarism or duplicate publication.
- Data fabrication or falsification.
- Ethical issues involving human or animal research.
- Undisclosed conflicts of interest.
- Any other concerns affecting research integrity.
REVIEWER RECOGNITION
JBFMM values the essential contribution of reviewers to the peer-review process. Reviewer contributions may be acknowledged through certificates, annual acknowledgments, or other recognition initiatives in accordance with journal policies while maintaining reviewer confidentiality.
CONTACT INFORMATION
For questions regarding the review process or ethical concerns, please contact:
Editorial Office: contact@scitxthub.com
We thank all reviewers for their time, expertise, and commitment to maintaining the quality, integrity, and scientific excellence of research published in the Journal of Biomedical Frontiers and Molecular Medicine (JBFMM).
